Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
4 Single-dose vials Discard unused portion Lilly PACKAGE LABEL - Zepbound Single-Dose Vial - 7.5 mg/0.5 mL Dose PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 0002-1214-04 Zepbound (tirzepatide) injection 7.5 mg/0.5 mL Rx Only For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
Your healthcare provider can help develop an individualized plan for monitoring and managing the transition off tirzepatide, including adjustments to other medications and strategies for maintaining therapeutic benefits achieved during treatment
Even small deviations in water volume change your concentration and throw off every subsequent dose calculation
FDA-approved Tirzepatide (Mounjaro & Zepbound): These medications have been through extensive clinical trials to prove they are safe, effective, and of high quality
Many providers have a BMI eligibility limit, but Emerge didnt bring any of that up during the process
